[Several new inhibitors of gastric secretion]
- PMID: 28254
[Several new inhibitors of gastric secretion]
Abstract
In experiments on dogs, milid (proglymid) entailed a weak inhibition of the 2nd phase of the gastric secretion leaving intact the 1st phase. The action of LS-519 was obvious in the 1st phase, having entailed a significant inhibition. The glycomacropeptid exerted a strong inhibiting effect both on the 1st and the 2nd phases, the effect lasting longer than that of the first two drugs. All the three drugs not only inhibited the gastric secretion but increased pH, reduced the gastric juice acidity while exerting no significan effect on concentration of common proteinases.
Similar articles
-
[A model for assessment of gastric antisecretory power: application to proglumide (author's transl)].Gastroenterol Clin Biol. 1977 Aug-Sep;1(8-9):643-51. Gastroenterol Clin Biol. 1977. PMID: 913963 French. No abstract available.
-
[Action of some gastric antisecretory drugs on histamine H2-receptors (author's transl)].Ateneo Parmense Acta Biomed. 1978;49(3):249-56. Ateneo Parmense Acta Biomed. 1978. PMID: 33682 Italian.
-
[Effect of prolonged pirenzepin administration on the gastric cell populations in the rat (author's transl)].Gastroenterol Clin Biol. 1978 Dec;2(12):1001-9. Gastroenterol Clin Biol. 1978. PMID: 33866 French. No abstract available.
-
The spectrum of inhibition of gastric acid secretion.Surg Annu. 1979;11:207-24. Surg Annu. 1979. PMID: 41329 Review. No abstract available.
-
New histamine H2-receptor antagonists.Hepatogastroenterology. 1980 Jun;27(3):163-8. Hepatogastroenterology. 1980. PMID: 6109690 Review. No abstract available.